US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 8.670
  • +0.360+4.33%
Close Nov 1 16:00 ET
  • 8.670
  • 0.0000.00%
Post 20:01 ET
1.01BMarket Cap-5100P/E (TTM)

About Arcutis Biotherapeutics Company

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Company Profile

SymbolARQT
Company NameArcutis Biotherapeutics
Listing DateJan 31, 2020
Issue Price17.00
Founded2016
CEOMr. Todd Franklin Watanabe
MarketNASDAQ
Employees296
Fiscal Year Ends12-31
Address3027 Townsgate Road,Suite 300
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-805-418-5006

Company Executives

  • Name
  • Position
  • Salary
  • Todd Franklin Watanabe
  • Director, President and Chief Executive Officer
  • 4.94M
  • L. Todd Edwards
  • Senior Vice President and Chief Commercial Officer
  • 1.66M
  • Dr. Patrick Burnett, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.67M
  • Bethany Dudek
  • Chief Technical Officer
  • --
  • Matthew Richard Moore
  • Senior Vice President and Chief Business Officer
  • --
  • David J. Topper
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Masaru Matsuda, J.D.
  • Senior Vice President and General Counsel
  • --
  • Patrick J. Heron
  • Chairman of the Board
  • 181.24K
  • Dr. Howard G. Welgus, M.D.
  • Director
  • 144.24K
  • Terrie Curran
  • Independent Director
  • 148.74K
  • Neha Krishnamohan
  • Independent Director
  • 148.74K
  • Sue-Jean Lin
  • Independent Director
  • 163.74K
  • Halley E. Gilbert
  • Independent Director
  • 148.74K
  • Dr. Bhaskar Chaudhuri,PhD
  • Independent Director
  • 153.74K
  • Keith R. Leonard, Jr
  • Independent Director
  • 146.24K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data